Stay updated with breaking news from Sciences Provides Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company's lead clinical program, L-130, a proprietary stabilized...
30.11.2022 - PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) - 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company and its regulatory consultants from the US and the UK, met with the UK Medicines ... Seite 1